China’s Stocks Rebound, Led by Drugmakers, Consumer Companies

China’s stocks rebounded, capping a second week of gains for the benchmark index, as concerns about faster inflation and a property bubble spurred investors to switch to drugmakers and other so-called defensive industries.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.